WWW.KONF.X-PDF.RU
- , ,
 


Pages:     | 1 |   ...   | 6 | 7 || 9 | 10 |

- 14.03.09 ...

-- [ 8 ] --

54. Alonso, A. Lck dephosphorylation at Tyr-394 and inhibition of T-cell antigen receptor signaling by Yersinia phosphatase YopH / A. Alonso, N. Bottini, S. Bruckner, S. Rahmouni, S. Williams, S.P. Schoenberger, T. Mustelin // J. Biol.

Chem. 2004. N 279. . 4922-4928.

55. Amedei, A. Role of immune response in Yersinia pestis infection / A. Amedei, E. Niccolai, L. Marino, M.M. DElios // J. Infect. Dev. Ctries. 2011. N 5 (9). . 628-639.

56. Andersson, H. Transcriptional profiling of host responses in mouse lungs following aerosol infection with type A Francisella tularensis / H. Andersson, B. Hartmanova, R. Kuolee, P. Ryden, W. Conlan, W. Chen, A. Sjostedt // J. Med.

Microbiol. 2006. N 55. . 263-271.

57. Anisimov, A.P. Amino acid and structural variability of Yersinia pestis LcrV protein / A.P. Anisimov, S.V. Dentovskaya, E.A. Panfertsev, T.E. Svetoch, P.Kh. Kopylov, B.W. Segelke, A. Zemla, M.V. Telepnev, V.L. Motin // Infect. Genet.

Evol. 2010. N 10 (1). . 137-145.

58. Anisimov, A.P. Treatment of plaque: promising to antibiotics / A.P. Anisimov, K.K. Amoako // J. of Medical Microbiology. 2006. N 55 (11). P. 1461-1475.

59. Anisimov, A.P. Intraspecies and temperature-dependent variations in susceptibility of Yersinia pestis to the bactericidal action of serum and to polymyxin B / A.P. Anisimov, S.V. Dentovskaya, G.M. Titareva, I.V. Bakhteeva, R.Z. Shaikhutdinova, S.V. Balakhonov, B. Lindner, N.A. Kocharova, S.N. Senchenkova, O. Holst, G.B. Pier, Y.A. Knirel // Infect. Immun. 2005. N 73. . 7324-7331.

60. Fortier, A.H. Live Vaccine Strain of Francisella tularensis: Infection and Immunity in Mice / A.H. Fortier, M.V. Slayter, R. Ziemba, M.S. Meltzer, C.A. Nacy // Infecion and immunity. 1991. N 9. . 2922-2928.

61. Anthony, L.D. Growth of Francisella spp. in rodent macrophages / L.D. Anthony, R.D. Burke, F.E. Nano // Infect. Immun. 1991. N 59. . 3291-3296.

62. Anthony, L.S. Isolation of a Francisella tularensis mutant that is sensitive to serum and oxidative killing and is avirulent in mice: correlation with the loss of MinD homologue expression / L.S. Anthony, S.C. Cowley, K.E. Mdluli, F.E. Nano // FEMS Microbiol. Lett. 1994. N 124. . 157-165.

63. Auerbuch, V. Growth of Yersinia pseudotuberculosis in mice occurs independently of Toll-like receptor 2 expression and induction of interleukin-10 / V. Auerbuch, R.R. Isberg // Infect. Immun. 2007. N 75. . 3561-3570.

64. Avgustin, B. CD69 expression on CD4+ T lymphocytes after in vitro stimulation with tuberculin is an indicator of immune sensitization against Mycobacterium tuberculosis antigens / B. Avgustin, V. Kotnik, M. Skoberne, T. Malovrh, A. Skralovnik-Stern, M. Tercelj // Clin. Diagn. Lab. Immunol. 2005. N 12 (1). . 101-106.

65. Azuma, M. B70 antigen is a second ligand for CTLA-4 and CD28 / M. Azuma, D. Ito, K. Okumara, J.H. Phillips, L.L. Lanier, C. Somoza // Nature. 1993.

N 366. . 76-79.

66. Baecher-Allan, C. MHC Class II Expression Identies Functionally Distinct Human Regulatory T Cells / C. Baecher-Allan, E. Wolf, D.A. Haer // J. Immunol. 2006. N 176. . 4622-4631.

67. Bakshi, C.S. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain / C.S. Bakshi, M. Malik, M. Mahawar, G.S. Kirimanjeswara, K.R. Hazlett, L.E. Palmer, M.B. Furie, R. Singh, J.A. Melendez, T.J. Sellati, D.W. Metzger // Vaccine. 2008. N 26. . 5276-5288.

68. Balagopal, A. Characterization of the receptor-ligand pathways important for Francisella tularensis entry and survival of in human macrophages / A. Balagopal, A.S. MacFarlane, N. Mohapatra, S. Soni, J.S. Gunn, L.S. Schlesinger // Infect. Immun. 2006. N 74. . 5114-5125.

69. Ballesteros-Tato, A. CD4+ T helper cells use CD154-CD40 interactions to counteract T reg cell-mediated suppression of CD8+ T cell responses to influenza / A. Ballesteros-Tato, B. Len, F.E. Lund, T.D. Randall // J. Exp. Med. 2013. N 210(8). . 1591-601.

70. Barel, M. A novel receptor-ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu / M. Barel, A.G. Hovanessian, K. Meibom, J.P. Briand, M. Dupuis, A. Charbit // BMC Microbiol. 2008. N 8. . 145.

71. Baron, S.D. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion / S.D. Baron, R. Singh, D.W. Metzger // Infect. Immun. 2007. N 75. . 2152-2162.

72. Bartra, S.S. Resistance of Yersinia pestis to complementdependent killing is mediated by the Ail outer membrane protein / S.S. Bartra, K.L. Styer, D.M. OBryant, M.L. Nilles, B.J. Hinnebusch, A. Aballay, G.V. Plano // Infect. Immun. 2008. N 76.

. 612-622.

73. Bashaw, J. Development of in vitro correlate assays of immunity to infection with Yersinia pestis / J. Bashaw, S. Norris, S. Weeks, S. Trevino, J.J. Adamovicz, S. Welkos // Clin. Vaccine Immunol. 2007. N 14 (5). . 605-616.

74. Bei, Li. Humoral and Cellular Immune Responses to Yersinia pestis Infection in Long-Term Recovered Plague Patients / Li Bei, Du Chunhong, Zhou Lei, Bi Yujing, Wang Xiaoyi, Wen Li, Guo Zhaobiao, Song Zhizhong, Yang Ruifu // Clinical and Vaccine Immunology. 2012. N 19 (2). . 228-234.

75. Ben Nasr, A. Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria / A. Ben Nasr, J. Haithcoat, J.E. Masterson, J.S. Gunn, T. Eaves-Pyles, G.R. Klimpel // J. Leukoc. Biol. 2006. N 80. . 774-786.

76. Ben-Efraim, S. New antigenic component of Pasteurella pestis formed under specified conditions of pH and temperature / S. Ben-Efraim, M. Aronson, L. Bichowsky-Slomnicki // J. Bacteriol. 1961. N 81 (5). . 704-714.

77. Berg, M. Regulation of CD28 expression on CD8 T cells by CTLA-4 / M. Berg, N. Zavazava // Journal of Leukocyte Biology. 2008. N 83. . 853-863.

78. Bernasconi, N.L. A role for Toll-like receptors in acquired immunity: upregulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells / N.L. Bernasconi, Nobuyuki Onai, A. Lanzavecchia // Blood. 2003. N 101 (11). . 4500-4504.

79. Bevanger, L. Agglutinins and antibodies to Francisella tularensis outer membrane antigens in the early diagnosis of disease during an outbreak of tularemia / L. Bevanger, J.A. Maeland, A.I. Naess // J. Clin. Microbiol. 1988. N 26 (3). . 433-437.

80. Bitsaktsis, C. Differential requirements for protection against mucosal challenge with Francisella tularensis in the presence versus absence of cholera toxin B and inactivated F. tularensis / C. Bitsaktsis, D.B. Rawool, Y. Li, N.V. Kurkure, B. Iglesias, E.J. Gosselin // J. Immunol. 2009. N 182. . 4899-4909.

81. Bland, D.M. Imaging Early Pathogenesis of Bubonic Plague: Are Neutrophils Commandeered for Lymphatic Transport of Bacteria? / D.M. Bland, D.M. Anderson // MBio. 2013. N 5 (4). . e00837-13.

82. Bokhari, S.M. NK cells and gamma interferon coordinate the formation and function of hepatic granulomas in mice infected with the Francisella tularensis live vaccine strain / S.M. Bokhari, K.J. Kim, D.M. Pinson, J. Slusser, H.W. Yeh, M.J. Parmely // Infect. Immun. 2008. N 76. . 1379-1389.

83. Bonquist, L. MglA and Igl proteins contribute to the modulation of Francisella tularensis live vaccine strain-containing phagosomes in murine macrophages / L. Bonquist, H. Lindgren, I. Golovliov, T. Guina, A. Sjostedt // Infect.

Immun. 2008. N 76. . 3502-3510.

84. Borriello, F. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation / F. Borriello, M.P. Sethna, S.D. Boyd, A.N. Schweitzer, E.A. Tivol, D. Jacoby, T.B. Strom, E.M. Simpson, G.J. Freeman, A.H. Sharpe // Immunity. 1997. N 6. . 303-313.

85. Bouaziz, J.D. Regulatory B cells as inhibitors of immune responses and inflammation / J.D. Bouaziz, K.Yanaba, T.F. Tedder // Immunol. Rev. 2008. N 224.

. 201-214.

86. Braciale, V.L. Correlates of immunity elicited by live Yersinia pestis vaccine / V.L. Braciale, M. Nash, N. Sinha, I.V. Zudina, V.L. Motin. In: V.S. Georgiev, K.A. Western, J.J. McGowan, editors // National Institute of Allergy and Infectious Diseases, NIH: Frontiers in Research. Totowa, NJ, Humana Press. 2008. N 1. . 473-480.

87. Brubaker, R.R. Interleukin-10 and inhibition of innate immunity to yersiniae:

roles of Yops and LcrV (V antigen) // Infect. Immun. 2003. N 71 (7). . 3673-3681.

88. Burke, D.S. Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia // J. Infect. Dis. 1977. N 135. . 55-60.

89. Butler, T. Plague and Other Yersinia Infections // New York: Plenum Press. 1983. 124 .

90. Cayer, M.P. 2-Methoxyestradiol induce the conversion of human peripheral blood memory B lymphocytes into plasma cells / M.P. Cayer, M. Drouin, M. Proulx, D. Jung // J. Immunol. Methods. 2010. N 355(1-2). . 29-39.

91. Chalton, D.A. A functional monomeric plague vaccine created by circular permutation / D.A. Chalton, J.A. Musson, H.C. Flick-Smith // Infection and immunity. 2006. N 74. . 6624-6631.

92. Charity, J.C. Twin RNA polymerase-associated proteins control virulence gene expression in Francisella tularensis / J.C. Charity, M.M. Costante-Hamm, E.L. Balon, D.H. Boyd, E.J. Rubin, S.L. Dove // PLoS Pathog. 2007. N 3. . e84.

93. Chatterjee, S. Filarial Infection Modulates the Immune Response to Mycobacterium tuberculosis through Expansion of CD4+ IL-4 Memory T Cells / S. Chatterjee, C.E. Clark, E. Lugli, M. Roederer, T.B. Nutman // J. Immunol. 2015. 194 (6). - . 2706-2714.

94. Chen, P.E. Genomic characterization of the Yersinia genus / P.E. Chen, C. Cook, A.C. Stewart, N. Nagarajan, D.D. Sommer, M. Pop, B. Thomason, M.P. Thomason, S. Lentz, N. Nolan, S. Sozhamannan, A. Sulakvelidze, A. Mateczun, L. Du, M.E. Zwick, T.D. Read // Genome Biol. 2010. N 11 (1). . R1.

95. Chen, W. Toll-like receptor 4 (TLR4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A Francisella tularensis / W. Chen, R. KuoLee, H. Shen, M. Bsa, J.W. Conlan // Microb. Pathog. 2004. N 37 (4). . 185-191.

96. Chen, W. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background / W. Chen, H. Shen, A. Webb, R. KuoLee, J.W. Conlan // Vaccine. 2003. N 21 (25-26). . 3690-700.

97. Chong, A. The early phagosomal stage of Francisella tularensis determines optimal phagosomal escape and Francisella pathogenicity island protein expression / A. Chong, T.D. Wehrly, V. Nair, E.R. Fischer, J.R. Barker, K.E. Klose, J. Celli // Infect.

Immun. 2008. N 76. . 5488-5499.

98. Lucas, C.R. Sanders Prohibitins and the Cytoplasmic Domain of CD86 Cooperate to Mediate CD86 Signaling in B Lymphocytes / C.R. Lucas, H.M. Cordero-Nieves, R.S. Erbe, J.W. McAlees, S. Bhatia, R.J. Hodes, K.S. Campbell, Virginia M // J. Immunol. 2013. N 190 (2). . 723-736.

99. Clausen, J. Functional significance of the activationassociated receptor D25 and CD69 on human NKcells and NKlike Tcells / J. Clausen, B. Vergeiner, M. Enk // Immunobiology. 2003. N 207 (2). . 85-93.

100. Clay, C.D. Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen / C.D. Clay, S. Soni, J.S. Gunn, L.S. Schlesinger // J. Immunol. 2008. N 181. . 55685578.

101. Clemens, D.L. Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages / D.L. Clemens, B.Y. Lee, M.A. Horwitz // Infect. Immun. 2004. N 72. . 3204-3217.

102. Cole, L.E. Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge / L.E. Cole, Y. Yang, K.L. Elkins, E.T. Fernandez, N. Qureshi, M.J. Shlomchik, L.A.

Herzenberg, S.N. Vogel // Proc. Natl. Acad. Sci. U.S.A. 2009. N 106. . 4343-4348.

103. Cole, L.E. Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages / L.E. Cole, K.A. Shirey, E. Barry, A. Santiago, P. Rallabhandi, K.L. Elkins, A.C. Puche, S.M. Michalek, S.N. Vogel // Infect. Immun. 2007. N 75. . 4127-4137.

104. Collins, A.V. The interaction properties of costimulatory molecules revisited / A.V. Collins, D.W. Brodie, R.J. Gilbert, A. Iaboni, R. Manso-Sancho, B. Walse, D.I. Stuart, P.A. van der Merwe, S.J. Davis // Immunity. 2002. N 17. . 201-210.

105. Conlan, W.J. Infection of Mice with Francisella as an Immunological Model / W.J. Conlan, W. Chen, C.M. Bosio, S.C. Cowley, K.L. Elkins // Curr. Protoc.

Immunol. 2011. N 4. . Unit 1914.

106. Conlan, J.W. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T celland interferon gamma-dependent mechanism / J.W. Conlan, H. Shen, R. Kuolee, X. Zhao, W. Chen // Vaccine. 2005. N 23. . 2477-2485.

107. Conlan, J.W. Mice intradermally-inoculated with the intact lipopolysaccharide, but not the lipid A or O-chain, from Francisella tularensis LVS rapidly acquire varying degrees of enhanced resistance against systemic or aerogenic challenge with virulent strains of the pathogen / J.W. Conlan, E. Vinogradov, M.A. Monteiro, M.B. Perry // Microb. Pathog. 2003. N 34 (1). . 39-45.

108. Conlan, J.W. Different host defences are required to protect mice from primary systemic vs pulmonary infection with the facultative intracellular bacterial pathogen, Francisella tularensis LVS / J.W. Conlan, R. KuoLee, H. Shen, A. Webb // Microb. Pathog. 2002. N 32. . 127-134.

109. Conlan, J.W. Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes / J.W. Conlan, R.J. North // Infect. Immun. 1992. N 60. . 5164-5171.

110. Cornelis, G.R. The Yersinia YscYop type III weaponry // Nat. Rev. Mol.

Cell. Biol. 2002. N 3. . 742-752.

111. Cornelis, G.R. Yersinia type III secretion: send in the effectors // J. Cell.

Biol. 2002. N 158. . 401-408.

112. Cornelis, G.R. The Yersinia Ysc-Yop virulence apparatus // Int. J. Med.

Microbiol. 2002. N 291. . 455-462.

113. Cowan, C. Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis / C. Cowan, A.V. Philipovskiy, C.R. Wulff-Strobel, Z. Ye, S.C. Straley // Infect. Immun. 2005. N 73 (9). . 6127-6137.

114. Cowley, S. Immunity to Francisella / S. Cowley, K. Elkins // Front Microbiol. 2011. N 2. . 26.

115. Cowley, S.C. Lung CD4-CD8-doublenegative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain / S.C. Cowley, A.I. Meierovics, J.A. Frelinger, Y. Iwakura, K.L. Elkins // J. Immunol. 2010. N 184. . 5791-5801.

116. Cowley, S.C. Editorial: Proinflammatory cytokines in pneumonic tularemia:

too much too late? // J. Leukoc. Biol. 2009. N 86 (3). . 469-470.

117. Cowley, S.C. CD4-CD8-T cells control intracellular bacterial infections both in vitro and in vivo / S.C. Cowley, E. Hamilton, J.A. Frelinger, J. Su, J. Forman, K.L. Elkins // J. Exp. Med. 2005. N 202. . 309-319.

118. Crane, D.D. Lipids derived from virulent Francisella tularensis broadly inhibit pulmonary inflammation via toll-like receptor 2 and peroxisome proliferatoractivated receptor / D.D. Crane, R. Ireland, J.B. Alinger, P. Small, C.M. Bosio // Clin. Vaccine. Immunol. 2013. N 20 (10). . 1531-1540.

119. Crane, D.D. A novel role for plasminmediated degradation of opsonizing antibody in the evasion of host immunity by virulent, but not attenuated, Francisella tularensis / D.D. Crane, S.L. Warner, C.M. Bosio // J. Immunol. 2009. N 183. . 4593-4600.

120. Craven, R.R. Francisella tularensis invasion of lung epithelial cells / R.R. Craven, J.D. Hall, J.R. Fuller, S. Taft-Benz, T.H. Kawula // Infect. Immun. 2008.

N 76. . 2833-2842.

121. Clemens, D.L. Francisella tularensis Enters Macrophages via a Novel Process Involving Pseudopod Loops / D.L. Clemens, Bai-Yu Lee, M.A. Horwitz // Infection and immunity. 2005. N 9. . 5892-5902.

122. Clemens, D.L. Virulent and Avirulent Strains of Francisella tularensis Prevent Acidification and Maturation of Their Phagosomes and Escape into the Cytoplasm in Human Macrophages / D.L. Clemens, Bai-Yu Lee, M.A. Horwitz // Infect. Immun. 2004 N 6. . 3204-3217.

123. Darling, R.G. USAMRIIDs medical management of biological casualties handbook / R.G. Darling, J.B. Woods // 5th ed. Fort Detrick. 2004. 123 .

124. Dartevelle, S. Development and Evaluation of Two Simple, Rapid Immunochromatographic Tests for the Detection of Yersinia pestis Antibodies in Humans and Reservoirs Minoarisoa Rajerison / S. Dartevelle, M. Rajerison, L.A. Ralafiarisoa, I. Bitam, T.N. Dinh, V. Andrianaivoarimanana, F. Nato, L. Rahalison // PLoS Neg. Trop. Dis. 2009. N 3 (4). . e421.

125. Darzynkiewicz, Z. Features of apoptotic cells measured by flow cytometry / Z. Darzynkiewicz, S. Bruno, G. Del Bino, W. Gorczyca, M.A. Hotz, P. Lassota, F. Traganos // Cytometry. 1992. N 13. . 795-808.

126. Davis, S.J. The nature of molecular recognition by T cells / S.J. Davis, S. Ikemizu, E.J. Evans, L. Fugger, T.R. Bakker, P.A. van der Merwe // Nat. Immunol. 2003. N 4. . 217-224.

127. De Groot, A. From genome to vaccine: in silico predictions, ex vivo verification / A. De Groot, A. Bosma, N. Chinai, J. Frost, B. Jesdale, M. Gonzalez, W.

Martin, C. Saint-Aubin // Vaccine. 2001. N 19 (31). . 4385-4395.

128. Dennis, D.T. Tularemia as a biological weapon: medical and public health management / D.T. Dennis, T.V. Inglesby, D.A. Henderson, J.G. Bartlett, M.S. Ascher, E. Eitzen, A.D. Fine, A.M. Friedlander, J. Hauer, M. Layton, S.R. Lillibridge, J.E. McDade, M.T. Osterholm, T. OToole, G. Parker, T.M. Perl, P.K. Russell, K. Tonat // JAMA. 2001. N 285. . 2763-2773.

129. Derksen, P.W. Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma / P.W. Derksen, R.M. Keehnen, L.M. Evers, M.H. van Oers, M. Spaargaren, S.T. Pals // Blood. 2002.

N 99. . 1405-1410.

130. De Seabra, R.D. Effects of Virulence and Fraction 1 antigens from Yersinia pestis on the human innate immune system: PhD in Biochemistry // University of Sussex. 2011. 187 p.

131. Devdariani, Z.L. Comparative incidence of detection of specific antibodies to Yersinia pestis capsular antigen and lipopolysaccharide in humans immunized with pest vaccine / Z.L. Devdariani, V.A.Feodorova, O.V. Gromova, T.M. Taranenko // Klin.

Lab. Diagn. 1997. N 4. . 39-41.

132. Do, Y. Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor / Y. Do, A.M. Didierlaurent, S. Ryu, H. Koh, C.G. Park, S. Park, D.S. Perlin, B.S. Powell, R.M. Steinman // Vaccine. 2012.

N 30 (45). . 6359-67.

133. 412Du, Y. Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis / Y. Du, R. Rosqvist, A. Forsberg // Infect Immun. 2002. N 70. . 1453-1460.

134. Duckett, N.S. Intranasal interleukin-12 treatment for protection against respiratory infection with the Francisella tularensis live vaccine strain / N.S. Duckett, S. Olmos, D.M. Durrant, D.W. Metzger // Infect. Immun. 2005. N 73. . 2306-2311.

135. Dueas, A.I. Laboratory diagnosis and serologic course in patients with tularemia / A.I. Dueas, M. Ortega, I. Garrote, M. de Frutos, P. Gutirrez, A. Garca-Pascual, M. Cuervo, B. Hernndez Novoa, M.A. Bratos, A. Almaraz, A. Ordua, A. Rodrguez Torres // Med. Clin. (Barc). 2010. N 114 (11). . 407-410.

136. Dueas, A.I. Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like receptor 4 with much lower potency than E. coli LPS / A.I. Dueas, M. Aceves, A. Ordua, R. Daz, M. Snchez Crespo, C. Garca-Rodrguez // Int. Immunol. 2006. N 18 (5). . 785-795.

137. Dziarski, R. Deadly plague versus mild-mannered TLR4 // Nature Immunology 2006. N 7. . 1017-1019.

138. Ehrenkranz, N.J. Studies on immunization against plague. VIII. Study of three immunizing preparations in protecting primates against pneumonic plague / N.J. Ehrenkranz, K.F. Meyer // J. Infect. Dis. 1955. N 96. .138-144.

139. Eisele, N.A. Chemokine receptor CXCR2 mediates bacterial clearance rather than neutrophil recruitment in a murine model of pneumonic plague / N.A. Eisele, H. Lee-Lewis, C. BeschWilliford, C. R. Brown, D. M. Anderson // Am. J. Pathol. 2011. N 178. . 1190-1200.

140. Eisen, R.J. Adaptive strategies of Yersinia pestis to persist during interepizootic and epizootic periods / R.J. Eisen, K.L. Gage // Vet. Res. 2009. N 40 (2). . 1-9.

141. El Sahly, H.M. Safety, Reactogenicity and Immunogenicity of Francisella tularensis Live Vaccine Strain in Humans / H.M. El Sahly, R.L. Atmar, S.M. Pate, J.M. Wells, T. Cate, M. Ho, K. Guo, M.F. Pasetti, D.E. Lewis, M.B. Sztein, W.A. Keitel // Vaccine. 2009. N 27 (36). . 4905-4911.

142. Elkins, K.L. Survival of secondary lethal systemic Francisella LVS challenge depends largely on interferon gamma / K.L. Elkins, S.M. Colombini, A.I. Meierovics, M.C. Chu, A.Y. Chou, S.C. Cowley // Microbes Infect. 2010. N 12. . 28-36.

143. Elkins, K.L. Innate and adaptive immunity to Francisella / K.L. Elkins, S.C. Cowley, C.M. Bosio // Ann. N. Y. Acad. Sci. 2007. N 1105. . 284-324.

144. Elkins, K.L. Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain / K.L. Elkins, S.C. Cowley, C.M. Bosio // Microbes Infect. 2003. N 5. . 132-142.

145. Ellis, J. Tularemia / J. Ellis, P.C. Oyston, M. Green, R.W. Titball // Clinical.

Microbiol. Rev. 2002 N 10. . 631-646.

146. Elvin, S.J. Evolutionary genetics: ambiguous role of CCR5 in Yersinia pestis infection / S.J. Elvin, E.D. Williamson, J.C. Scott, J.N. Smith, G. Perez De Lema, S. Chilla, P. Clapham, K. Pfeffer, D. Schlondorff, B. Luckow // Nature. 2004. N 22 (430). . 417.

147. Elvin, S.J. Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague / S.J. Elvin, E.D. Williamson // Microb. Pathog. 2004. Vol. 37, N 4. . 177-184.

148. Elvin, S.J. The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses / S.J. Elvin, E.D. Williamson // Microbial Pathogenesis. 2000. Vol. 29, N 4. . 223-230.

149. Emelianova O.S. Characteristics of tularemia vaccinal strains according to laboratory indices // Zh. Mikrobiol. Epidemiol. Immunobiol. 1957. N 28. . 125-129.

150. Enesltt, K. Signatures of T Cells as Correlates of Immunity to Francisella tularensis / K. Enesltt, M. Normark, R. Bjrk, C. Rietz, C. Zingmark, L.A. Wolfraim, S. Stven, A. Sjstedt // PLoS One. 2012. N 7 (3). . e32367.

151. Enesltt, K. Persistence of cell-mediated immunity three decades after vaccination with the live vaccine strain of Francisella tularensis / K. Enesltt, C. Rietz, P. Ryden, S. Stven, R.V. House, K. Enesltt, C. Rietz, P. Rydn, S. Stven, R.V. House, L.A. Wolfraim, A. Trnvik, A. Sjstedt // Eur. J. Immunol. 2011. N 4.

. 974-980.

152. Ericson, M. Persisitance of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis 25 years after natural infection / M. Ericson, G. Sandstrm, A. Sjstedt, A. Trnvik // The journal of infectious diseases. 1994. N 170 (1). P. 110-116.

153. Erova, T.E. Evaluation of Protective Potential of Yersinia pestis Outer Membrane Protein Antigens as Possible Candidates for a New-Generation Recombinant Plague Vaccine / T.E. Erova, J.A. Rosenzweig, J. Sha, G. Suarez, J. C. Sierra, M.L. Kirtley, C.J. van Lier, M.V. Telepnev, V.L. Motin, A.K. Chopraa // Clinical and Vaccine Immunology. 2013. N 20 (2). . 227-238.

154. Eyles, J.E. Protection afforded against aerosol challenge by systemic immunisation with inactivated Francisella tularensis live vaccine strain (LVS) / J.E. Eyles, M.G. Hartley, T.R. Laws, P.C. Oyston, K.F. Griffin, R.W. Titball // Microb.

Pathog. 2008. N 44 (2). . 164-168.

155. Fearon, D.T. Arrested differentiation, the self-renewing memory lymphocyte, and vaccination / D.T. Fearon, P. Manders, S.D. Wagner // Science. 2001. N 293. . 248-250.

156. Felek, S. Three Yersinia pestis adhesins facilitate Yop delivery to eukaryotic cells and contribute to plague virulence / S. Felek, T. M. Tsang, E. S. Krukonis // Infect. Immun. 2010. N 78. . 4134-4150.

157. Feodorova, V.A. Serologic Markers for Long-Term Immunity in Humans Vaccinated with Live Yersinia pestis EV NIIEG / V.A. Feodorova, A.M. Lyapinaa, O.V. Ulianovaa, E.P. Lyapinab, L.V. Sayapinad, M.N. Lyapina, A.A. Shcherbakove, M.V. Telepnevf, V.L. Motin // Procedia in Vaccinology. 2012. N 6. . 10-13.

158. Feodorova, V.A. Plague vaccines: current developments and future perspectives / V.A. Feodorova, V.L. Motin // Emerging Microbes and Infections. 2012. N 1. . e36.

159. Feodorova, V.A. Plague vaccines / V.A. Feodorova, V.L. Motin // Kerala, India: Research Signpost 2011. . 175-233.

160. Feodorova, V.A. Prospects for new plague vaccines / V.A. Feodorova, M.J. Corbel // Expert Rev. Vaccines. 2009. N 8. . 1721-38.

161. Fetherston, J.D. The pigmentation locus of Yersinia pestis KIM61 is flanked by an insertion sequence andincludes the structural genes for pesticin sensitivity and HMWP2 / J.D. Fetherston, R.D. Perry // Mol. Microbiol. 1994. N 13. . 697-708.

162. Fetherston, J.D. Loss of the pigmentation phenotype in Yersinia pestis is due to the spontaneous deletion of 102 kb of chromosomal DNA which is flanked by are petitive element / J.D. Fetherston, P. Schuetze, R.D. Perry // Mol. Microbiol. 1992. N 6. . 2693-2704.

163. Fields, K.A. Virulence role of V antigen of Yersinia pestis at the bacterial surface / K.A. Fields, M.L. Nilles, C. Cowan, S.C. Straley // Infect. Immun. 1999. N 67 (10). . 5395-5408.

164. Foligne, B. Prevention and treatment of colitis with Lactococcus lactissecreting the immunomodulatory Yersinia LcrV protein / B. Foligne, R. Dessein, M. Marceau, S. Poiret, M. Chamaillard, B. Pot // Gastroenterology. 2007. N 133. . 862-874.

165. Forestal, C.A. Francisella tularensis has a significant extracellular phase in infected mice / C.A. Forestal, M. Malik, S.V. Catlett, A.G. Savitt, J.L. Benach, T.J. Sellati, M.B. Furie // J. Infect. Dis. 2007. N 196. . 134-137.

166. Forsman, M. Analysis of 16S ribosomal DNA sequences of Francisella strains and utilization for determination of the phylogeny of the genus and for identification of strains by PCR / M. Forsman, G. Sandstrom, A. Sjostedt // Int. J. Syst.

Bacteriol. 1994. N 44. . 38-46.

167. Fortier, A.H. Growth of Francisella tularensis LVS in macrophages: the acidic intracellular compartment provides essential iron required for growth / A.H. Fortier, D.A. Leiby, R.B. Narayanan, E. Asafoadjei, R.M. Crawford, C.A. Nacy, M.S. Meltzer // Infect. Immun. 1995. N 63. . 1478-1483.

168. Fortier, A.H. Life and death of an intracellular pathogen: Francisella tularensis and the macrophage / A.H. Fortier, S.J. Green, T. Polsinelli, T.R. Jones, R.M. Crawford, D.A. Leiby, K.L. Elkins, M.S. Meltzer, C.A. Nacy // Immunol. 1994.

N 60. . 349-361.

169. Foshay, L. Tularemia // Annu. Rev. Microbiol. 1950. N 4. . 313-330.

170. Lund, F.E. Effector and regulatory B cells: modulators of CD4+ T cell immunity / F.E. Lund, T.D. Randall. // Nat. Rev. Immunol. 2010. N 10 (4). . 236-247.

171. Francis, E. Antitularemic serum / E. Francis, L.D. Felton // Public Health Rep. 1942. N 57. . 44-55.

172. Freeman, G.J. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation / G.J. Freeman, J.G. Gribben, V.A. Boussiotis, J.W. Ng, V.A.J. Restivo, L.A. Lombard, G.S. Gray, L.M. Nadler // Science. 1993. N 262. . 909-911.

173. Fujita, H. The entry and intracellular multiplication of Francisella tularensis in cultured cells: its correlation with virulence in experimental mice / H. Fujita, Y. Watanabe, T. Sato, Y. Ohara, M. Homma // Microbiol. Immunol. 1993. N 37. . 837-842.

174. Fuller, C.L. Transcriptome analysis of human immune responses following live vaccine strain (LVS) Francisella tularensis vaccination / C.L. Fuller, K.C. Brittingham, M.W. Porter, M.J. Hepburn, P.L. Petitt, P.R. Pittman, S. Bavari // Mol. Immunol. 2007. N 44. . 3173-3184.

175. Fuller, C.L. Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination / C.L. Fuller, K.C. Brittingham, M.J. Hepburn, J.W. Martin, P.L. Petitt, P.R. Pittman, S. Bavari // J. Allergy Clin.

Immunol. 2006. N 117. . 1186-1188.

176. Fulton, K.M. Immunoproteomic analysis of the human antibody response to natural tularemia infection with Type A or Type B strains or LVS vaccination / K.M. Fulton, X. Zhao, M.D. Petit, S.L.N. Kilmury, L.A. Wolfraim, R.V. House, A. Sjostedt, S.M. Twine // Int. J. Med. Microbiol. 2011. N 301 (7). . 591-601.

177. Galvn, E.M. The Psa fimbriae of Yersinia pestis interact with phosphatidylcholine on alveolar epithelial cells and pulmonary surfactant / E.M. Galvn, H. Chen, D.M. Schifferli // Infect. Immun. 2007. N 75 (3). . 1272-1279.

178. Gao, J.J. Regulation of gene expression in mouse macrophages stimulated with bacterial CpG-DNA and lipopolysaccharide / J.J. Gao, V. Diesl, T. Wittmann, D.C. Morrison, J.L. Ryan, S.N. Vogel, M.T. Follettie // J. Leukoc. Biol. 2002. N 72. . 1234-1245.

179. Geier, H. Phagocytic receptors dictate phagosomal escape and intracellular proliferation of Francisella tularensis / H. Geier, J. Celli // Infect. Immun. 2011. N 79. . 2204-2214.

180. Gelman, A.E. Toll-Like Receptor Ligands Directly Promote Activated CD4+ T Cell Survival / A.E. Gelman, Jidong Zhang, Yongwon Choi, L.A. Turka // J. Immunol. 2004. N 172 (10). . 6065-6073.

181. Gillard, J.J. Modeling early events in Francisella tularensis pathogenesis / J.J. Gillard, T.R. Laws, G. Lythe, C. Molina-Pars // Front Cell Infect Microbiol. 2014. N 11 (4). . 169.

182. Gillette, D.D. Monocyte/macrophage inflammatory response pathways to combat Francisella infection: possible therapeutic targets? / D.D. Gillette, S. Tridandapani, J.P. Butchar // Front. Cell Infect. Microbiol. 2014. N 21 (4). . 18.

183. Girard, G. Immunity in plague infection. Results of 30 years of work with the Pasteurella pestis EV strain (Girard and Robic) // Biol Med (Paris). 1963. N 52.

. 631-731.

184. Golovliov, I. An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells / I. Golovliov, V. Baranov, Z. Krocova, H. Kovarova, A. Sjostedt // Infect. Immun. 2003. N 71. . 5940-5950.

185. Gomez, M. Identification of secreted proteins of Mycobacterium tuberculosis by a bioinformatic approach / M. Gomez, S. Johnson, M. Gennaro // Infect.

Immun. 2000. N 66. . 2323-2327.

186. Gonzalez, P.A. T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell / P.A. Gonzalez, L.J. Carreno, D. Coombs, J.E. Mora, E. Palmieri, B. Goldstein, S.G. Nathenson, A.M. Kalergis // Proc Natl Acad Sci USA. 2005. N 102. . 4824-4829.

187. Gonzlez-Amaro, R. Is CD69 an effective brake to control inflammatory diseases? / R. Gonzlez-Amaro, J.R. Corts, F. Snchez-Madrid, P. Martn // Trends Mol. Med. 2013. N 19 (10). . 625-632.

188. Good-Jacobson, K.L. CD80 Expression on B Cells Regulates Murine T Follicular Helper Development, Germinal Center B Cell Survival, and Plasma Cell Generation / K.L. Good-Jacobson, E. Song, Sh. Anderson, A.H. Sharpe, M.J. Shlomchik // The Journal of Immunology. 2012. N 188 (9). . 4217-4225.

189. Green, M. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease / M. Green, G. Choules, D. Rogers, R.W. Titball // Vaccine. 2005. N 23. . 2680-2686.

190. Green, M. The SCID/Beige mouse as a model to investigate protection against Yersinia pestis / M. Green, D. Rogers, P. Russell, A.J. Stagg, D.L. Bell, S.M. Eley, R.W. Titball, E.D. Williamson // FEMS Immunol Med. Microbiol. 1999. N 23 (2). . 107-113.

191. Grewal, I. CD40 and CD154 in cell-mediated mmunity / I. Grewal, R. Flavell // Annu Rev. Immunol. 1998. N 16. P. 111-135.

192. Hkansson, S. The Yersinia YpkA Ser/Thr kinase is translocated and subsequently targeted to the inner surface of the Hela cell plasma membrane / S. Hkansson, E.E. Galyov, R. Rosqvist, H. Wolf-Woatz // Mol. Microbiol. 1996. N 20. P. 593-603.

193. Hambleton, P. Vaccine potencies of the live vaccine strain of Francisella tularensis and isolated bacterial components / P. Hambleton, C.G. Evans, A.M. Hood, R.E. Strange // Br. J. Exp. Pathol. 1974. N 55. . 363-373.

194. Han, Y. Comparative transcriptomics in Yersinia pestis: a global view of environmental modulation of gene expression / Y. Han, J. Qiu, Z. Guo, H. Gao, Y. Song, D. Zhou // BMC Microbiol. 2007. N 7. . 96.

195. Hara, T. Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens, and antigens / T. Hara, L.K. Jung, J.M. Bjorndahl, S.M. Fu // J. Exp. Med. 1988. N 164. . 1988-2005.

196. Harris, D.P. Reciprocal regulation of polarized cytokine production by effector B and T cells / D.P. Harris, L. Haynes, P.C. Sayles, D.K. Duso, S.M. Eaton, N.M. Lepak, L.L. Johnson, S.L. Swain, F.E. Lund // Nature Immunol. 2000. N 1. . 475-482.

197. Hathcock, K.S. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation / K.S. Hathcock, G. Laszlo, H.B. Dickler, J. Bradshaw, P. Linsley, R.J. Hodes // Science. 1993. N 262. . 905-907.

198. Heath, D.G. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine / D.G. Heath, G.W. Anderson, J.M. Mauro. // Vaccine. 1998. Vol. 16, N. 11-12. . 1131-1137.

199. Heesemann, J. Yersinia s stratagem: targeting innate and adaptive immune defense / J. Heesemann, A. Sing, K. Trulzsch // Curr. Opin. Microbiol. 2006. N 9 (1). . 55-61.

200. Hollenbaugh, D. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity / D. Hollenbaugh, L.S. Grosmaire, C.D. Kullas // EMBO J. 1992. N 11. . 4313-4321.

201. Hong, K.J. Current status of vaccine development for tularemia preparedness / K.J. Hong, P.G. Park, S.H. Seo, G.E. Rhie, K.J. Hwang // Clin. Exp.

Vaccine Res. 2013. N 2 (1). . 34-39.

202. Horzempa, J. Invasion of erythrocytes by Francisella tularensis / J. Horzempa, D.M. O'Dee, D.B. Stolz, J.M. Franks, D. Clay, G.J. Nau // J. Infect. Dis. 2011. N 204. . 51-59.

203. Horzempa, J. Global transcriptional response to mammalian temperature provides new insight into Francisella tularensis pathogenesis / J. Horzempa, P.E. Carlson Jr, D.M. O'Dee, R.M. Shanks, G.J. Nau // BMC Microbiol. 2008. N 8.

. 172.

204. Huang, X.Z. The pH 6 antigen is an antiphagocytic factor produced by Yersinia pestis independent of Yersinia outer proteins and capsule antigen / X.Z. Huang, L.E. Lindler // Infect. Immun. 2004. N 72 (12). . 7212-7219.

205. Huggins, J. CpG DNA activation and plasma-cell differentiation of CD27naive human B cells / J. Huggins, T. Pellegrin, R.E. Felgar, C. Wei, M. Brown, B. Zheng, E.C. Milner, S.H. Bernstein, I. Sanz, M.S. Zand // Blood. 2007. Vol. 109, N 4. . 1611-1619.

206. Hui-Fang Teng, Y. Molecular functions of syndecan-1 in disease / Y. HuiFang Teng, R.S. Aquino, P. Woo Park // Matrix Biol. 2012. N 31 (1). . 3-16.

207. Huntley, J.F. Native Outer Membrane Proteins Protect Mice against Pulmonary Challenge with Virulent Type A Francisella tularensis / J.F. Huntley, P.G. Conley, D.A. Rasko, K.E. Hagman, M.A. Apicella, M.V. Norgard // Infect. Immun. 2008. N. 76(8) . 3664.

208. Inglesby, T.V. Plague as a biological weapon Medical and public health management / T.V. Inglesby, D.T. Dennis, D.A. Henderson, J.G. Bartlett, M.S. Ascher, E. Eitzen // Jama-Journal of the American Medical Association. 2000. N 283 (17). . 2281-2290.

209. Isherwood, K.E. Vaccination strategies for Francisella tularensis / K.E. Isherwood, R.W. Titball, D.H. Davies, P.L. Felgner, W.J. Morrow // Advanced Drug Delivery Reviews. 2005. N 57. . 1403-1414.

210. Janssen, W.A. Plague bacillus: survival within host phagocytes / W.A. Janssen, M.J. Surgalla // Science. 1969. N 163. . 950-952.

211. Janssens, S. Role of Toll-like receptors in pathogen recognition / S. Janssens, R. Beyaert // Clin. Microbiol. 2003. N 16. . 637-646.

212. Huggins, J. CpG DNAactivation and plasma-cell differentiation of CD27 naive human B cells / J. Huggins, T. Pellegrin, R.E. Felgar, Chungwen Wei, M. Brown, Bo Zheng, Eric C.B. Milner, S.H. Bernstein, I. Sanz, M.S. Zand // Blood. 2007. Vol. 109, N 4. . 1611-1619.

213. Johansson, A. Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia / A. Johansson, L. Berglund, U. Eriksson, I. Gransson, R. Wollin, M. Forsman, A. Trnvik, A. Sjstedt // J. Clin. Microbiol. 2000. N 38. . 22-26.

214. Jones, S.M. Protective ecacy of a fully recombinant plague vaccine in the guinea pig / S.M. Jones, K.F. Grin, I. Hodgson, E.D. Williamson // Vaccine. 2003. Vol. 21, N 25-26. . 3912-3918.

215. Saikh, Kamal U. Human Monocytes Infected with Yersinia pestis Express Cell Surface TLR9 and Differentiate into Dendritic Cells / Kamal U. Saikh, T.L.

Kissner, A. Sultana, G. Ruthel, R.G. Ulrich // J. Immunol. 2004. N 173. . 7426-7434.

216. Katkere, B. Effects of interferon- and Francisella tularensis elicited soluble factors on macrophage antigen processing / B. Katkere, J.E. Wilson, J.R. Drake // The FASEB Journal. 2008. N 22. . 1068.8.

217. Katz, J. Toll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVS / J. Katz, P. Zhang, M. Martin, S.N. Vogel, S.M. Michalek // Infect. Immun. 2006. N 74. . 2809-2816.

218. Ke, Y. Yersinia pestis: mechanisms of entry into and resistance to the host cell / Y. Ke, Z. Chen, R. Yang // Frontiers in Cellular and Infection Microbiology. 2013. N 3. Article 106.

219. Keasey, S.L. / S.L. Keasey, K.E. Schmid, M.S. Lee, J. Meegan, P.

Tomas, M. Minto, A.P. Tikhonov, B. Schweitzer, R.G. Ulrich// Mol. Cell Proteomics.

2009. N 8 (5). . 924-935.

220. Khlebnikov, V.S. Outer membranes of a lipopolysaccharide-protein complex (LPS-17 kDa protein) as chemical tularemia vaccines / V.S. Khlebnikov, I.R. Golovliov, D.P. Kulevatsky, N.V. Tokhtamysheva, S.F. Averin, V.E. Zhemchugov, S.Y. Pchelintsev, S.S. Afanasiev, G.Y. Shcherbakov // FEMS Immunol. Med.

Microbiol. 1996. Vol. 13. P. 227-233.

221. Kieffer, T.L. Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis / T.L. Kieffer, S. Cowley, F.E. Nano, K.L. Elkins // Microbes Infect. 2003. N 5. . 397-403.

222. Kirimanjeswara, G.S. Prophylactic and therapeutic use of antibodies for Francisella tularensis protection against respiratory infection with / G.S. Kirimanjeswara, J.M. Golden, C.S. Bakshi, D.W. Metzger // J. Immunol. 2007.

N 179. . 532-539.

223. Knight, S.D. Structure and assembly of Yersinia pestis F1 antigen // Adv.

Exp. Med. Biol. 2007. N 603. . 74-87.

224. Kolodziejek, A.M. Outer membrane protein X (Ail) contributes to Yersinia pestis virulence in pneumonic plague and its activity is dependent on the lipopolysaccharide core length / A.M. Kolodziejek, D.R. Schnider, H.N. Rohde, A.J. Wojtowicz, G.A. Bohach, S.A. Minnich, C.J. Hovde // Infect. Immun. 2010. N 78. . 5233-5243.

225. Kolodziejek, A.M. Phenotypic characterization of OmpX, an Ail homologue of Yersinia pestis KIM / A.M. Kolodziejek, D.J. Sinclair, K.S. Seo, D.R. Schnider, C.F.

Deobald, H. Rohde, A.K. Viall, S.S. Minnich, C. Hovde, S.A. Minnich, G.A. Bohach // Microbiology. 2007. N 153. . 2941-2951.

226. Komai-Koma, M. TLR2 is expressed on activated T cells as a costimulatory receptor / M. Komai-Koma, L. Jones, G.S. Ogg, D. Xu, F.Y. Liew // PNAS. 2004. N 101 (9). . 3029-3034.

227. Koskela, P. Cell-mediated immunity against Francisella tularensis after natural infection / P. Koskela, E. Herva // Scand J. Infect. Dis. 1980. N 12. . 281-287.

228. Kumar, H. NLRC5 deficiency does not influence cytokine induction by virus and bacteria infections / H. Kumar, J. Pandey S Zou, Y. Kumagai, K. Takahashi, S. Akira, T. Kawai // J. Immunol. 2011. N 186 (2). . 994-1000.

229. Lahteenmaki, K. Bacterial metastasis: the host plasminogen system in bacterial invasion / K. Lahteenmaki, S. Edelman, T.K. Korhonen // Trends Microbiol. 2005. N 13 . 79-85.

230. Lahteenmaki, K. Expression of plasminogen activator Pla of Yersinia pestis enhances bacterial attachment to the mammalian extracellular matrix / K. Lahteenmaki, R. Virkola, A. Saren, L. Emody, T.K. Korhonen // Infect. Immun. 1998. N 66. . 5755-5762.

231. Lai, X.H. Delineation of the molecular mechanisms of Francisella tularensis-induced apoptosis in murine macrophages / X.H. Lai, A. Sjostedt // Infect.

Immun. 2003. N 71. . 4642-4646.

232. Laird, R.M. T Cells Acquire Effector Fates in the Thymus and Differentiate into Cytokine-Producing Effectors in a Listeria Model of Infection Independently of CD28 Costimulation / R.M. Laird, B.J. Wolf, M.F. Princiotta, S.M. Hayes // PLoS One. 2013. N 8 (5). . e63178.

233. Lanzavecchia, A. Receptor-mediated antigen uptake and its effect on antigen presentation to class-II restricted T lymphocytes // Annu. Rev. Immunol. 1990. N 8.

. 773-793.

234. Latz, E. Mechanisms of TLR9 activation / E. Latz, A. Visintin, T. Espevik, D.T. Golenbock // J. Endotoxin Res. 2004. N 10 (6). . 406-412.

235. Lauriano, C.M. MglA regulates transcription of virulence factors necessary for Francisella tularensis intraamoebae and intramacrophage survival / C.M. Lauriano, J.R. Barker, S.S. Yoon // Proc. Natl. Acad. Sci USA. 2004. N 101. . 4246-4249.

236. Lavine, C.L. Immunization with heat-killed Francisella tularensis LVS elicits protective antibody-mediated immunity / C.L. Lavine, S.R. Clinton, I. Angelova Fischer, T.N. Marion, X.R. Bina, J.E. Bina, M.A Whitt, M.A. Miller // Eur. J. Immunol.

2007. N 37. . 3007-3020.

237. Lawrenz, M.B. A novel autotransporter adhesin is required for efficient colonization during bubonic plague / M.B. Lawrenz, J.D. Lenz, V.L. Miller // Infect.

Immun. 2009. N 77. . 317-326.

238. Lee, K.P. The genomic organization of the CD28 gene. Implications for the regulation of CD28 mRNA expression and heterogeneity / K.P. Lee, C. Taylor, B. Petryniak, L.A. Turka, C.H. June, C.B. Thompson // J. Immunol. 1990. N 145. . 344-352.

239. Lefrancois, L. Intestinal and pulmonary mucosal T cells: local heroes fight to maintain the status quo / L. Lefrancois, L. Puddington // Annu Rev. Immunol. 2006. N 24. . 681-704.

240. Lembo, A. Administration of a synthetic TLR4 agonist protects mice from pneumonic tularemia / A. Lembo, M. Pelletier, R. Iyer, M. Timko, J.C. Dudda, T.E. West, C.B. Wilson, A.M. Hajjar, S.J. Skerrett // J. Immunol. 2008. N 180. . 7574-7581.

241. Li, L. Mycobacterium tuberculosis-specific polyfunctional cytotoxic CD8+ T cellsexpress CD69 / L. Li, B. Yang, X. Zhang, S. Lao, Wu. Changyou // Tuberculosis (Edinb). 2014. N 94 (3). . 219-25.

242. Li, B. Humoral and cellular immune responses to Yersinia pestis infection in long-term recovered plague patients / B. Li, C. Du, L. Zhou, Y. Bi, X. Wang, L. Wen, Z. Guo, Z. Song, R. Yang // Clin. Vaccine Immunol. 2012. N 19 (2). . 228-234.

243. Li, L. Identification of M. tuberculosis-specific Th1 cells expressing CD69 generated in vivo in pleural fluid cells from patients with tuberculous pleurisy / L. Li, D. Qiao, X. Fu, S. Lao, X. Zhang, C. Wu // PLoS One. 2011. N 6 (8). . e23700.

244. Li, B. High-throughput identication of new protective antigens from a Yersinia pestis live vaccine by enzyme-linked immunospot assay / B. Li, L. Zhou, J. Guo, X. Wang, B. Ni, Y. Ke, Z. Zhu, Z. Guo, R. Yang // Infect.Immun. 2009. N 77. . 4356-4361.

245. Lin, J.S. IL-17 Contributes to Cell-Mediated Defense against Pulmonary Yersinia pestis Infection / J.S. Lin, L.W. Kummer, F.M. Szaba, S.T. Smiley // Immunol.

2011. N 186 (3). . 1675-1684.

246. Lin, J.S. TNF and IFN contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague / J.S. Lin, S. Park, J.J. Adamovicz, J. Hill, J.B. Bliska, C.K. Cote, D.S. Perlin, K. Amemiya, S.T. Smiley // Vaccine. 2010. N 29 (2). . 357-62.

247. Lin, Y. Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis / Y. Lin, S. Ritchea, A. Logar, S. Slight, M. Messmer, J. Rangel-Moreno, L. Guglani, J.F. Alcorn, H. Strawbridge, S.M. Park, R. Onishi, N. Nyugen, M.J. Walter, D. Pociask, T.D. Randall, S.L. Gaffen, Y. Iwakura, J.K. Kolls, S.A. Khader // Immunity. 2009. Vol. 31 (5), N 20. . 799-810.

248. Linsley, P.S. The role of CD28 receptor during T-cell responses to antigen / P.S. Linsley, J.A. Ledbetter // Annu Rev. Immunol. 1993. N 11. . 191-212.



Pages:     | 1 |   ...   | 6 | 7 || 9 | 10 |
 

:

03.02.03 03.01.06 ( ) ...

( ) 25.00.36 ( ) - - 201...

06.02.02 , , , : ...

- 14.01.11 : . . 2015 1. 13 ...

03.02.07 06.01.05 ...

Ȼ 14.01.11 : , .. 2015 1. ...

- Stevia rebaudiana (Bertoni) Hemsley 06.01.05 ...

, 14.03.09 , : , ...

- - CERASUS MILL. : 06.01.05. ...

: , : 05.18.07 : ,...

- - 03.02.08 ( ) : ...

03.02.10 ...

- 14.03.09 14.01.03 , : ...

03.02.08 ( ) : ...

(SORBUS L.) 03.02.01 : ..., ... .. 2014 .. 4 1. .. 8 ...

03.01.06 ( ) : ...

03.02.08 : , 2014 . 1. 1.1 ...

˨ (COLUBRIDAE) : , , 03.02.08 () ( ) : , .. 2015 1. ...

PINUS KORAIENSIS (, , ) 03.02.14 : , . . 2015 .. 4 1 ...

SACCHAROMYCES CEREVISIAE 03.02.07 : .. - - 1. ....







 
<<     |    
2016 www.konf.x-pdf.ru - - , ,

, .
, , , , 1-2 .